Detalles de la búsqueda
1.
Health-related quality of life in patients with newly diagnosed advanced ovarian cancer treated with niraparib vs placebo: Results from the phase 3 randomized PRIMA/ENGOT-OV26/GOG-3012 trial.
Gynecol Oncol
; 184: 168-177, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38325276
2.
Niraparib, Dostarlimab, and Bevacizumab as Combination Therapy in Pretreated, Advanced Platinum-Resistant Ovarian Cancer: Findings From Cohort A of the OPAL Phase II Trial.
JCO Precis Oncol
; 8: e2300693, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38754056
3.
Pharmacokinetics and safety of niraparib in patients with moderate hepatic impairment.
Cancer Chemother Pharmacol
; 88(5): 825-836, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34324028
Resultados
1 -
3
de 3
1
Próxima >
>>